Brodalumab
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 704 publications
Improvement of interstitial lung disease during brodalumab treatment in a patient with psoriasis and systemic immune-mediated inflammation.
Journal: European journal of dermatology : EJD
Published: September 06, 2026
IL-17A Restrains Antiviral Immunity to Promote Chikungunya Virus Infection and Pathogenesis in the Heart.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.
Journal: The Journal of dermatological treatment
Published: August 12, 2026
Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis.
Journal: Journal of drugs in dermatology : JDD
Published: August 05, 2026
Beyond the Usual Targets: A Case Report of Overcoming IL-23 and IL-17A Biologic Nonresponse in Palmoplantar Psoriasis With Brodalumab.
Journal: The Journal of clinical and aesthetic dermatology
Published: July 22, 2026
Immunobiological Therapy in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study Investigating the Effects of Inadequate Therapeutic Compliance on Drug Survival.
Journal: Dermatology and therapy
Published: May 19, 2026
IL-17 inhibitor therapy and risk of chronic obstructive pulmonary disease and related pulmonary outcomes in patients with psoriasis: A real-world cohort study.
Journal: Respiratory medicine
Published: May 07, 2026
INDIVIDUAL ARTICLE: Clinical and Real-World Implications of IL-17 Receptor Blockade in Plaque Psoriasis and Psoriatic Arthritis With Brodalumab.
Journal: Journal of drugs in dermatology : JDD
Published: May 04, 2026
Short-term efficacy of biologics targeting the IL-17/IL-23 axis in scalp, nail, and palmoplantar psoriasis: a network meta-analysis of randomized controlled trials.
Journal: Frontiers in immunology
Published: April 02, 2026
Guizhi-Shaoyao-Zhimu Decoction Regulates the IL-17R-MAPK Pathway to Alleviate Rheumatoid Arthritis.
Journal: Journal of ethnopharmacology
Published: March 24, 2026
IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients.
Journal: The Journal of dermatology
Published: March 23, 2026
Last Updated: 09/26/2026